Not all of the dangerous, controversial drugs are banned in baseball

64 Comments

We get up in arms about testosterone and HGH — substances our bodies naturally produce and which have few serious side effects or long-lasting consequences — because they’re on a banned list. Meanwhile there’s a drug that a lot of athletes take under the direction and supervision of their teams which can kill people and is banned in several countries: the anti-inflammatory Toradol.

Gordon Edes of ESPN Boston has a story about its use in baseball. The hook: an interview with Jonathan Papelbon who took it routinely when he was with the Red Sox but who was told by the Phillies that he can no longer take it as they do not allow it.  Edes looks into the controversial drug, notes its serious side effects, which can include internal bleeding (Clay Buchholz believes it’s what led to him contracting esophagitis which landed him in the ICU) and notes that it’s banned in several countries, for athletes and normal folks alike.

Papelbon’s description of its use in Major League Baseball is pretty familiar-sounding: it’s taken before the game to help guys “get through a 162 game season.” It’s, by definition, a performance enhancing drug. It’s letting guys do things they otherwise couldn’t do. Allowing their bodies to recover faster which allows them to train harder and compete at a more intense level than they otherwise could. Except it’s not on a banned list so no one cares despite the fact that it has the potential to kill you.

There is a tremendous disconnect between the drugs people think are awful in sports and the drugs that truly have the potential to be harmful. This is maybe the best example. Might be nice if we thought about our priorities about these things once in a while.

Steven Matz likely to start season on DL; Zack Wheeler to adhere to innings limit

Joe Robbins/Getty Images
1 Comment

Mets manager Terry Collins said on Wednesday, “It’s unlikely that [Steven Matz] will start the season with us.” The final spot in the Mets’ starting rotation will go to either Zack Wheeler or Seth Lugo, Newsday’s Marc Carig reports.

On Wheeler’s innings limit, assistant GM John Ricco said, “There’s going to be some number but we don’t exactly know what that is.” Wheeler missed the last two seasons after undergoing Tommy John surgery.

Neither Wheeler nor Lugo have had terrific springs as each carries a 5.11 and 5.56 Grapefruit League ERA, respectively. However, Carig notes that Wheeler has impressed simply by appearing healthy and brandishing a fastball that once again sits in the mid- to high-90’s. Lugo, meanwhile, proved crucial to the Mets last year, posting a 2.67 ERA across eight starts and nine relief appearances.

Rockies sign 30-year lease to stay in Coors Field

Bart Young/Getty Images
6 Comments

Nick Groke of the Denver Post reports that the Rockies agreed to a $200 million, 30-year lease with the Metropolitan Baseball Stadium District, which is the state division that owns Coors Field. As part of the deal, the Rockies will lease and develop a plot of land south of the stadium, which will cost the team $125 million for 99 years.

As Groke points out, had the Rockies not reached a deal by Thursday, March 30, the lease would have rolled over for five more years.

Rockies owner Dick Monfort issued a statement, saying, “We are proud that Coors Field will continue to be a vital part of a vibrant city, drawing fans from near and far and making our Colorado residents proud.”

The Rockies moved into Coors Field in 1995. It is the National League’s third oldest stadium. In that span of time, the Rockies have made the playoffs three times, the last coming in 2009 when they lost in the NLDS to the Phillies. The Rockies were swept in the 2007 World Series by the Red Sox.